Triamcinolone diacetate

• Description:

  Triamcinolone diacetate is a synthetic derivative of glucocorticoid. Triamcinolone diacetate has anti-inflammatory activity. Triamcinolone diacetate can be used in research on dermatomyositis, Bell's palsy and rheumatoid arthritis[1][2][3].

• UNSPSC:

  12352211

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  Glucocorticoid Receptor

• Related Pathways:

  Immunology/Inflammation; Vitamin D Related/Nuclear Receptor

• Field of Research:

  Inflammation/Immunology

• Smiles:

  C[C@@]12[C@](C[C@H]([C@]2(O)C(COC(C)=O)=O)OC(C)=O)([H])[C@@]3([H])[C@]([C@H](C1)O)([C@@]4(C(CC3)=CC(C=C4)=O)C)F

• Molecular Formula:

  C25H31FO8

• Molecular Weight:

  478.51

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]KIRSCHBAUM JO. Dermatomyositis: treated with triamcinolone diacetate. Conn Med. 1959 Feb;23 (2) :69-72.|[2]PAULSON G, SATRAN R. Treatment of Bell's palsy with triamcinolone diacetate. Dis Nerv Syst. 1963 Apr;24:237-40. |[3]Zuckner J. Treatment of Rheumatoid Arthritis by Intramuscular Triamcinolone Acetonide and Triamcinolone Diacetate. Ann Rheum Dis. 1961 Sep;20 (3) :274-80.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  67-78-7